Ocular Findings of Myotonic Dystrophy Type 1 in the Korean Population

Overview

Journal Graefes Arch Clin Exp Ophthalmol

Specialty Ophthalmology

Date 2016 Jan 28

PMID 26816296

Citations 3

Authors

Se Hyun Choi

Hee Kyung Yang

Jeong-Min Hwang

Kyung Seok Park

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate ocular findings in a Korean population with myotonic dystrophy type 1 (DM1).

Methods: A total of 24 Korean patients with DM1, ranging in age from 4 to 71 years, were examined over a period from June 2004 to May 2014. Ophthalmologic examinations including visual acuity assessment, slit-lamp biomicroscopy, ocular motility, cycloplegic refraction, and fundus examination were performed in all patients, and brain magnetic resonance (MR) imaging was performed in 15 patients.

Results: The ocular findings, in order of decreasing prevalence, were as follows: cataract (17 patients, 71 %), myopia (22 eyes, 59 %), hyperopia (13 eyes, 35 %), ptosis (6 patients, 25 %), epiretinal membrane (5 patients, 21 %), exotropia (4 patients, 17 %), ocular motility limitations (4 patients, 17 %), blepharitis (2 patients, 8 %), pigmentary retinopathy (2 patients, 8 %), lid lag (1 patient, 4 %), esotropia (1 patient, 4 %), and myelinated nerve fiber layer (1 patient, 4 %). Five of eight patients (63 %) with CTG repeats ≥ 700 underwent cataract extraction, as did one of 13 patients (8 %) with CTG repeats < 700 (P = 0.014). All four patients who showed limited ocular motility had CTG repeats ≥ 1000. Brain MR imaging showed periventricular white matter lesions in three patients, diffuse brain atrophy in two patients, and extraocular muscle atrophy in two patients.

Conclusions: Korean patients with DM1 showed a high incidence of exotropia in comparison to Caucasian patients with DM1. Our study suggests a possible correlation between the severity of cataract and ocular motility limitation and the size of CTG repeats.

Citing Articles

Clinical and imaging clues to the diagnosis and follow-up of ptosis and ophthalmoparesis.

Keene K, Kan H, van der Meeren S, Verbist B, Tannemaat M, Beenakker J J Cachexia Sarcopenia Muscle. 2022; 13(6):2820-2834.

PMID: 36172973 PMC: 9745561. DOI: 10.1002/jcsm.13089.

Fundus flavimaculatus-like in myotonic dystrophy: a case report.

Kirkegaard-Biosca E, Berges-Marti M, Azarfane B, Cilveti E, Distefano L, Garcia-Arumi J BMC Ophthalmol. 2021; 21(1):240.

PMID: 34051736 PMC: 8164789. DOI: 10.1186/s12886-021-02002-5.

Ophthalmic findings in myotonic dystrophy type 2: a case series.

Kersten H, Danesh-Meyer H, Roxburgh R J Neurol. 2016; 263(12):2552-2554.

PMID: 27807619 DOI: 10.1007/s00415-016-8325-7.

References

Osanai R, Kinoshita M, Hirose K . Eye movement disorders in myotonic dystrophy type 1. Acta Otolaryngol Suppl. 2008; (559):78-84. DOI: 10.1080/03655230701597192. View

Kawasaki R, Wang J, Mitchell P, Aung T, Saw S, Wong T . Racial difference in the prevalence of epiretinal membrane between Caucasians and Asians. Br J Ophthalmol. 2008; 92(10):1320-4. DOI: 10.1136/bjo.2008.144626. View

Ranum L, Day J . Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet. 2004; 74(5):793-804. PMC: 1181975. DOI: 10.1086/383590. View

Bollen E, Den Heyer J, Tolsma M, Bellari S, Bos J, Wintzen A . Eye movements in myotonic dystrophy. Brain. 1992; 115 ( Pt 2):445-50. DOI: 10.1093/brain/115.2.445. View

Bollinger K, Kattouf V, Arthur B, Weiss A, Kivlin J, Kerr N . Hypermetropia and esotropia in myotonic dystrophy. J AAPOS. 2007; 12(1):69-71. DOI: 10.1016/j.jaapos.2007.08.005. View

Kimizuka Y, Kiyosawa M, Tamai M, Takase S . Retinal changes in myotonic dystrophy. Clinical and follow-up evaluation. Retina. 1993; 13(2):129-35. View

Yoon K, Mun G, Kim S, Kim S, Kim C, Park K . Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008-2009. Korean J Ophthalmol. 2011; 25(6):421-33. PMC: 3223710. DOI: 10.3341/kjo.2011.25.6.421. View

Koca M, Horn F, Korth M . Alterations of saccadic eye movements in myotonic dystrophy. Graefes Arch Clin Exp Ophthalmol. 1992; 230(5):437-41. DOI: 10.1007/BF00175929. View

Romeo V, Pegoraro E, Ferrati C, Squarzanti F, Soraru G, Palmieri A . Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2. J Neurol. 2010; 257(8):1246-55. DOI: 10.1007/s00415-010-5498-3. View

10.

Verhagen W, Huygen P . Abnormalities of ocular motility in myotonic dystrophy. Brain. 1997; 120 ( Pt 10):1907-9. DOI: 10.1093/brain/120.10.1907. View

11.

Anastasopoulos D, Kimmig H, Mergner T, Psilas K . Abnormalities of ocular motility in myotonic dystrophy. Brain. 1996; 119 ( Pt 6):1923-32. DOI: 10.1093/brain/119.6.1923. View

12.

Kersten H, Roxburgh R, Child N, Polkinghorne P, Frampton C, Danesh-Meyer H . Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1. J Neurol. 2013; 261(1):37-44. DOI: 10.1007/s00415-013-7141-6. View

13.

Kim M, Park K, Kim C, Jeoung J, Kim S . The distribution of intraocular pressure and associated systemic factors in a Korean population: the Korea National Health and Nutrition Examination Survey. Acta Ophthalmol. 2014; 92(7):e507-13. DOI: 10.1111/aos.12327. View

14.

Ajroud-Driss S, Sufit R, Siddique T, Hain T . Oculomotor involvement in myotonic dystrophy type 2. Muscle Nerve. 2008; 38(4):1326-9. DOI: 10.1002/mus.21113. View

15.

Brook J, McCurrach M, Harley H, Buckler A, Church D, Aburatani H . Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell. 1992; 69(2):385. DOI: 10.1016/0092-8674(92)90418-c. View

16.

Marchini C, Lonigro R, Verriello L, Pellizzari L, Bergonzi P, Damante G . Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin Genet. 2000; 57(1):74-82. DOI: 10.1034/j.1399-0004.2000.570112.x. View

17.

Dreyer R . Ocular hypotony in myotonic dystrophy. Int Ophthalmol. 1983; 6(3):221-3. DOI: 10.1007/BF00141131. View

18.

Wong V, Beckingsale P, Oley C, Sullivan T . Management of myogenic ptosis. Ophthalmology. 2002; 109(5):1023-31. DOI: 10.1016/s0161-6420(02)01009-6. View

19.

Osanai R, Kinoshita M, Hirose K . Saccadic slowing in myotonic dystrophy and CTG repeat expansion. J Neurol. 1998; 245(10):674-80. DOI: 10.1007/s004150050266. View

20.

Isashiki Y, Nakagawa M, Yamada H, Miyata M . [Ocular manifestations in mitochondrial DNA abnormalities]. Nippon Ganka Gakkai Zasshi. 1994; 98(1):3-12. View